Orphan drugs and regulatory affairs

I watched the live broadcast of “Orphan Drug & Rare Disease Development: Understanding the European and US Regulatory Landscape” today, hosted by XTalks and presented by Premier Research. Talking about the US regulatory scene, Nach Dave emphasised...